Solexa to Present at Leerink Swann & Company/MEDACorp Roundtable Conference
News May 05, 2006
Solexa, Inc. has announced that John West, chief executive officer of Solexa, and Linda Rubinstein, vice president & CFO, will make a presentation to the investment community at the Leerink Swann & Company/MEDACorp Roundtable Conference on Emerging Life Science Tools Products and Applications on Tuesday, May 9, 2006, at 2:15 p.m. Eastern Time (11:15 a.m. Pacific Time) at the Millennium Broadway Hotel in New York City.
Interested investors may gain access to a live audio webcast via the Internet by visiting the "Investors" section of the Company's Web site. The presentation will be archived on the Web site for 14 days.
In addition, Mr. West will participate in a panel discussion, "Emerging DNA Sequencing Technologies and Applications," moderated by John Sullivan and Irena Melnikova, Ph.D., of Leerink Swann.
The panel will also include other industry participants, including representatives of top-tier commercial and academic institutions.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.